Invasive fungal infections (IFIs) are associated with high morbidity and mortality in intensive care units. Candida species are the most important fungal pathogens and among the most frequent causes of infection in critically ill patients. Studies have evaluated the correlation between the onset of antifungal treatment and survival. However, definitive diagnosis of IFI is time-consuming in clinical practice. Antifungal prophylaxis and preemptive or empirical treatments are among therapeutic strategies to prevent or treat early fungal infections in selected patients. Recently, new evidence from randomized controlled trials and systematic reviews has been published. Moreover,newclinical practice guidelines from international communities are available. The aimof this review was to present updated evidence on this topic.

Cortegiani A., Russotto V., Iozzo P., Raineri S.M., & Giarratano A. (2017). What is the most recent evidence on the prevention and early treatment of invasive fungal infections in nonneutropenic critically ill patients?. ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 12(4) [10.5812/archcid.12414].

What is the most recent evidence on the prevention and early treatment of invasive fungal infections in nonneutropenic critically ill patients?

Cortegiani A.
;
Russotto V.;Iozzo P.;Raineri S. M.;Giarratano A.
2017

Abstract

Invasive fungal infections (IFIs) are associated with high morbidity and mortality in intensive care units. Candida species are the most important fungal pathogens and among the most frequent causes of infection in critically ill patients. Studies have evaluated the correlation between the onset of antifungal treatment and survival. However, definitive diagnosis of IFI is time-consuming in clinical practice. Antifungal prophylaxis and preemptive or empirical treatments are among therapeutic strategies to prevent or treat early fungal infections in selected patients. Recently, new evidence from randomized controlled trials and systematic reviews has been published. Moreover,newclinical practice guidelines from international communities are available. The aimof this review was to present updated evidence on this topic.
Cortegiani A., Russotto V., Iozzo P., Raineri S.M., & Giarratano A. (2017). What is the most recent evidence on the prevention and early treatment of invasive fungal infections in nonneutropenic critically ill patients?. ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 12(4) [10.5812/archcid.12414].
File in questo prodotto:
File Dimensione Formato  
archcid-12-04-12414 (1).pdf

accesso aperto

Tipologia: Versione Editoriale
Dimensione 102.89 kB
Formato Adobe PDF
102.89 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/411995
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact